Search for: "Abbott Products Inc" Results 501 - 520 of 664
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 May 2010, 11:27 am
Cir. 2005); Abbott Labs. v. [read post]
13 May 2010, 12:27 pm by Bexis
Abbott Laboratories, 2009 WL 2231701 (S.D.N.Y. [read post]
3 May 2010, 1:25 pm
Abbott Labs., 339 F.3d 1324 (Fed. [read post]
7 Apr 2010, 3:44 pm by admin
Under RCRA, EPA regulates hazardous waste from production to final disposal. [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP Factor)… [read post]
18 Mar 2010, 2:30 am
Abbott Laboratories (Patent Docs) Flomax (Tamsulosin) – US: The last shall be first... [read post]
11 Mar 2010, 4:08 pm by Dr. Shezad Malik
Abbott said the firm that hired Simon Loza Mejia, Freeway Transport Inc., was liable for the girl's injuries. [read post]
25 Feb 2010, 10:57 am by admin
The other three defendants include the City of West Point, West Point Dairy Products, LLC, (WPDP); and Wimmers Meat Products, Inc. [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]
24 Feb 2010, 2:11 am
(Patent Docs) US: PhRMA representative questions follow-on biologics paper (Patent Docs) USPTO announces agenda for next biotechnology/chemical/pharmaceutical customer partnership meeting (Patent Docs)   Products Arzerra (Ofatumumab) – US: Glaxo Group, GlaxoSmithKline seek declaratory judgment of invalidity and non-infringement against Genentech, City of Hope (Patent Docs) Cipro (Ciprofloxacin) – US: Bayer files patent infringement complaints against Lupin in Maryland and… [read post]